Potential OA Treatment - Chemokine CCL17 Inhibition Patients with osteoarthritis (OA) of the knee receiving an investigational chemokine inhibitor showed some improvements in pain and disability, said researchers with the drug's developer. https://t.co/MYYBBIIuDA https://t.co/1AfbxCuGIq